Continuing Education
for Urology & GU Oncology Clinicians
Washington, DC (UroToday.com) At the SUO 2019 meeting in Washington, DC, during the session on Penile Cancer, Dr. Jad Chahoud, a Genitourinary Medical Oncologist from the Moffitt Cancer Center, presented on Novel Systemic Therapies in Penile Cancer. He started his talk by giving a brief background of Penile Cancer. Penile Cancer is a rare disease in the United States, representing 0.7% of all cancers, with the majority of patients present with localized or locally advanced disease.
Non-Accredited
Washington, DC (UroToday.com) At the Penile Cancer session at the 2019 Society for Urologic Oncology Annual Meeting, Drs. Curtis Pettaway, Lance Paligaro, and Peter Johnstone presented updates on different aspects of the International Penile Advanced Cancer (InPACT) Trial.
Non-Accredited
Washington, DC (UroToday.com) Penile cancer is among the most disfiguring diseases encountered by the urologist in clinical practice. Treatment of this disease requires a careful balance of oncologic outcomes with preservation of sexual function, urinary function, and cosmesis. In this session, Dr. Philippe Spiess, a urologic oncologist from Moffit Cancer Center, presented options for organ preservation in penile cancer.
Non-Accredited
Washington, DC (UroToday.com) Following a number of presentations on penile cancer and the InPACT trial at the 20th Annual Meeting of the Society of Urologic Oncology, Dr. Vijay Sangar presented on the eUROGEN referral network. While encompassing penile cancer, this is a broader concept to provide guidance in the diagnosis and management for rare and complex urogenital conditions in Europe.
Non-Accredited